The US Supreme Court asked the Trump administration for input on an appeal from pharmaceutical and medical-device companies that are trying to stop a lawsuit accusing them of helping to finance terrorist attacks in Iraq.
The companies are seeking review of a ruling that let American terrorism victims sue the companies for allegedly paying millions of dollars in bribes to secure medical-supply contracts with the Iraqi Ministry of Health from 2004 to 2013. The victims say the money went to Jaysh al-Mahdi, a militant group that controlled the ministry.
The lawsuit names units of AstraZeneca Plc, Roche Holding Ltd., GE HealthCare Technologies Inc., Johnson & Johnson, Pfizer Inc. and Viatris Inc. as defendants. The companies were sued by service members and civilians who served in Iraq, as well as their families.
ALSO READ | With US midterms underway, courts rebuff Trump’s pressure on state election officials
The justices directed their request Monday to US Solicitor General D. John Sauer, the administration’s top Supreme Court lawyer.
The companies say they contracted with the ministry at the encouragement of the US government. They told the Supreme Court that, even if true, the allegations against them weren’t sufficient to let a lawsuit go forward under the US Anti-Terrorism Act.
\The drugmakers said the suit didn’t allege a sufficiently close connection between their transactions with the ministry and specific acts of terrorism. The companies also contended the law requires a showing that a defendant intended to help a terror attack succeed.
ALSO READ | US Supreme Court rebuffs Trump administration restrictions on medical care for transgender inmates
In urging the Supreme Court to reject the appeal, the victims said the companies knew their bribes financed attacks and yet continued paying for years. A federal appeals court in Washington ruled the suit could go forward, saying the complaint adequately alleged that the companies repeatedly structured their transactions in an unusual and illegal manner that facilitated Jaysh al-Mahdi’s activities.
The Supreme Court ruled unanimously in 2023 that the Anti-Terrorism Act couldn’t be used to hold social media companies responsible for a 2017 shooting in an Istanbul nightclub. Both sides in the Iraq case contended the court’s reasoning in the 2023 case supported their arguments.
The case is AstraZeneca UK v. Atchley, 26-245.
ALSO READ | Tesla, Samsung oppose US tariffs on Vietnam as steel and solar firms seek penalties